Inhibition and induction of human cytochrome P450 (CYP) enzymes

被引：306

作者：

Pelkonen, O ^{[1
]}

Mäenpää, J

Taavitsainen, P

Rautio, A

Raunio, H

机构：

[1] Univ Oulu, Dept Pharmacol & Toxicol, FIN-90220 Oulu, Finland

[2] Leiras OY, Clin Res, FIN-00101 Helsinki, Finland

来源：

XENOBIOTICA | 1998年 / 28卷 / 12期

关键词：

D O I：

10.1080/004982598238886

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：1203 / 1253

页数：51

共 267 条

[21]

Black DJ, 1996, DRUG METAB DISPOS, V24, P422

[22] HUMAN CYTOCHROMES-P-450 [J].

BOOBIS, AR ;

DAVIES, DS .

XENOBIOTICA, 1984, 14 (1-2) :151-185

[23] COMPARISON OF THE INVIVO AND INVITRO RATES OF FORMATION OF THE 3 MAIN OXIDATIVE METABOLITES OF ANTIPYRINE IN MAN [J].

BOOBIS, AR ;

BRODIE, MJ ;

KAHN, GC ;

TOVERUD, EL ;

BLAIR, IA ;

MURRAY, S ;

DAVIES, DS .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (06) :771-777

[24]

Bourrie M, 1996, J PHARMACOL EXP THER, V277, P321

[25] EXPRESSION OF A HUMAN-LIVER CYTOCHROME-P-450 PROTEIN WITH TOLBUTAMIDE HYDROXYLASE-ACTIVITY IN SACCHAROMYCES-CEREVISIAE [J].

BRIAN, WR ;

SRIVASTAVA, PK ;

UMBENHAUER, DR ;

LLOYD, RS ;

GUENGERICH, FP .

BIOCHEMISTRY, 1989, 28 (12) :4993-4999

[26] Drug therapy - Antiepileptic drugs [J].

Brodie, MJ ;

Dichter, MA .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :168-175

[27] FLUVOXAMINE IS A POTENT INHIBITOR OF CYTOCHROME-P4501A2 [J].

BROSEN, K ;

SKJELBO, E ;

RASMUSSEN, BB ;

POULSEN, HE ;

LOFT, S .

BIOCHEMICAL PHARMACOLOGY, 1993, 45 (06) :1211-1214

[28]

BROSEN K, 1993, CLIN INVESTIGATOR, V71, P1002

[29] CLINICAL-SIGNIFICANCE OF THE SPARTEINE-DEBRISOQUINE OXIDATION POLYMORPHISM [J].

BROSEN, K ;

GRAM, LF .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (06) :537-547

[30] Are pharmacokinetic drug interactions with the SSRIs an issue? [J].

Brosen, K .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 :23-27

← 1 2 3 4 5 6 7 8 9 10 →